FreshLeaf Analytics News

We attended the ODC’s consultation session on proposed medical cannabis license changes so you didn’t have to The Office of Drug Control (ODC) held consultation sessions in three capital cities over the last week seeking feedback on their proposed changes to Australia’s commercial medical cannabis licensing system. FreshLeaf attended the Sydney workshop on February 3rd...Read More

The TGA is re-examining the clinical evidence for medical cannabis – including over-the-counter CBD This is the third article in our series about the Department of Health’s submission to the Senate Inquiry into medical cannabis patient access. You can read the Department’s submission here. In December 2017 the TGA, in collaboration with several universities, produced...Read More

Department of Health releases new medical cannabis patient access info The TGA tends to avoid speaking about prescriptions because they have no direct oversight regarding scripts. Instead they focus on SAS-A/B approvals and AP notifications. These can be considered proxy figures for access. And if you have empirical data about prescriptions per approval, and empirical...Read More

Department of Health provides new commercial insights to Senate Inquiry The Senate Inquiry into the current barriers to patient access to medicinal cannabis in Australia has already revealed some fascinating new pieces of information on the performance of our medical cannabis framework. Public submissions to the Inquiry are available on the APH website and they...Read More

FreshLeaf’s top ten 2020 trends for Australia’s medical cannabis industry You don’t need a crystal ball to know that 2020 is going to be a big year for cannabis in Australia and around the world. But what does that mean exactly for companies, patients and regulators? Here are the top 10 most important trends in...Read More

New Zealand finalises medical cannabis regulations Today the Misuse of Drugs (Medicinal Cannabis) Regulations 2019 were published, setting out the regulations for a New Zealand cannabis industry and making significant changes to patient access. Here are the major features of New Zealand’s new scheme: Improved patient access Firstly, NZ doctors have been prescribing a variety...Read More

New Zealand draft recreational cannabis legislation released Whether you like it or not, having both medical and non-medical cannabis frameworks in place means there will be interaction between the two. Despite the qualitative differences between medical and non-medical products, services, regulations and patients/consumers, the legalisation of non-medical cannabis impacts medical users.  FreshLeaf Analytics and the...Read More

As medical cannabis access gets easier, governments will miss out on public health data Recent reforms at the State level in NSW and QLD mean increasing patient numbers will be traded off against quality data collection. This is good for patients but will make it harder for governments and industry to track market expansion. A...Read More